Celltrion Pharm Reports Q1 Operating Profit of 9.5 Billion KRW, Up 23% YoY
Celltrion Pharm announced on the 12th that its operating profit on a separate basis for the first quarter of this year was 9.55 billion KRW, an increase of 23.1% compared to the same period last year.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- [Breaking] Samsung Labor-Management 'Performance Bonus Negotiations' Fail in Third Mediation... Union Says "General Strike to Proceed as Planned Tomorrow"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Sales amounted to 90.01 billion KRW, up 1.4% from the same period last year. A Celltrion Pharm official said, "This quarter, major products in the chemical and biopharmaceutical sectors posted solid sales, showing a stable growth trend."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
